EXTERNAL QUALITY ASSESSMENT


protein material also highlights errors in electrolyte analysis that cannot be detected by other aqueous controls. Despite these advantages, aqueous- based material has poor buffering capacity and ability to dissolve gases, compared to fresh whole blood. This has most impact on pO2


measurements at low


concentration, with factors such as tubing length, chamber material and test time contributing to the variation between analysers. Thus, although this material allows comparison of pO2


performance


within peer groups, it is unsuitable for between-instrument comparisons. For this reason, Weqas also distribute a sample comprising tonometered bovine haemolysate on a yearly basis, to assess the accuracy of pO2


performance. This


material has similar oxygen saturation characteristics to fresh human blood and allows comparison of performance between different analysers.5


A 20-year retrospective study A retrospective study, covering over 20 years of pO2


distributions (2001-2023),


was conducted to compare the pO2 performance of laboratory and POCT


analysers, using both aqueous material and fresh bovine haemolysate. The use of POCT analysers has grown significantly over the past 25 years, with the proportion rising from just 7% of analysers in 2001, to 43% in 2010, reaching 95% in 2023 (Table 1). The performance, expressed as the bias against the all-method average was calculated for each analyser for the haemolysate and concentration matched aqueous samples and compared with the allowable analytical performance specification, the Weqas Total Allowable Error (TAE). The all-method average was used in preference to the overall mean to allow equal weighting for each method group. The Weqas TAE is based on Milan Model 3, ‘state of the art’ and is reviewed every two years.


The intra-variation (mean ± 2 SD) is shown as an error bar for each analyser for, 2011, 2015 and 2021 respectively, for the haemolysate matrix (Fig 2).


Study findings


The study showed that there was little change in the overall precision profile for pO2


<15 kPa for analysers prior


between 2001 and 2021 using the aqueous material, however, a much lower overall method CV was observed at a pO2


to 2000, reflecting use of laboratory- based blood gas analysers, rather than POC instruments. There was significant improvement in the inter-laboratory variation for the haemolysate compared with aqueous material at low pO2


Fig 2. Performance of blood gas analysers for pO2 material.


WWW.PATHOLOGYINPRACTICE.COM SEPTEMBER 2025


assessed using fresh tonometered haemolysate


39


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84